baber/WOPTO huggingface dataset:
Patent AU-676236-B2 (AU)
Title: Non woven multilayer material and hygienic absorbent article comprising such material
Inventor: KOCZAB JEAN-PIERRE
IPC: D04B21/14
Filed: 1993-11-18
Granted: 1997-03-06
Abstract: Multilayer nonwoven material which has a high rate of drying out, improved rate of entry of, or break-through time by, body fluids and good diffusion of the body fluids in the plane of the layers, comprises at least two superposed layers (1, 2) of natural or synthetic textile fibers, joined together, the fibers of the successive layers having a denier decreasing progressively, in a given direction, from one successive layer to the other. <IMAGE>
Patent AU-625524-B2 (AU)
Title: Curable resins with reduced foaming characteristics and articles incorporating same
Inventor: POLTA CHARLES CHRISTOPHER
IPC: D06M15/564
Filed: 1990-06-12
Granted: 1992-07-16
Abstract: The present invention relates to novel curable resins and orthopedic casting materials incorporating such, which experience reduced foaming during cure, decreased set times, and/or increased warm wet strength after cure. The resins contain a stable dispersion of hydrophobic polymeric particles which are responsible for the foregoing benefits. The polymeric particles preferably are made from vinyl monomers.
Patent AU-535679-B2 (AU)
Title: Movement monitoring device
Inventor: COHEN ELLIS BERNARD
IPC: G08B21/00
Filed: 1980-06-02
Granted: 1984-03-29
Abstract: A device for monitoring the physical activity of persons comprises a movement detector 8 electrically coupled to drive time-delay circuits [C2, R2, TR6, R6,][C4, R4, TR4, R5][C5, R7, TR8, R8,] the outputs of which are connected to drive an alarm device 10 such that in the presence of the movements detected by detector 8 the alarm device 10 is held in its OFF condition and is switched to its ON condition in the absence of such movements after a pertaining time-delay. The time-delay circuits are respectively arranged to provide time-delays of 30 seconds, 6 seconds, 40 seconds, with the first and second time-delay circuits being connected in series and the third time-delay circuit connected in parallel with the first two so that if the first timer circuit activates the alarm the second timer circuit provides a delay prior to latching of the alarm during which the alarm can be manually cancelled while the third timer circuit provides for fail-safe operation. The movement detector 8 comprises at least one tubular housing 5, containing a freely movable ball 5C and means for establishing an electrical output signal according to movement of the ball 5C or an acousto/electrical transducer or a mechanical/electric transducer. A pulse shaping and isolating circuit C1, R1 is located at the output of the detector 8 which provides pulses of predetermined amplitude and duration to the time-delay circuits within time intervals determined by the movement detector 8.
Patent AU-631091-B2 (AU)
Title: Polymer base blend compositions containing destructurized starch
IPC: C08L3/02
Filed: 1990-07-16
Granted: 1992-11-12
Abstract: A composition of matter capable of being formed into articles having substantial dimensional stability comprising     a) destructurized starch, and b) at least one polymer selected from the group of polysaccharides which have been chemically modified to contain added hydroxyalkyl groups and/or contain alkyl ether groups, and/or contain ester groups; said polymer being present in an amount effective to enhance the physical properties of said articles.   The composition may contain further conventional additives as well as hydrophobic substantially water-insoluble polymers.
Patent AU-617621-B2 (AU)
Title: Oxoindole derivative
Inventor: KAWAGUCHI AKIHIRO
IPC: A61K31/44
Filed: 1990-07-23
Granted: 1991-11-28
Abstract: Oxoindole derivatives of general formula (1), remarkably useful for treating senile dementia, i.e., improving brain functions and activating and protecting brain metabolism. In the formula, R<1> represents hydrogen, halogen, lower alkyl, or lower alkoxy; R<2> represents hydrogen or lower alkyl; R<3> represents -CH2-R<5>, wherein R<5> represents alkyl which may be cyclic, benzodioxanyl, or phenyl which may be substituted with a plurality of halogen, lower alkyl, lower alkoxy, hydroxy, diethylamino, trifluoromethyl, nitrile, nitro or benzyloxy; alternatively R<2> and R<3> may be combined together to from = CH-R<5>, wherein R<5> is as defined above; and R<4> represents 1 -propylbutyl, pyridyl, or phenyl which may be substituted with lower alkoxy, halogen, diethylamino, benzyloxy, trifluoromethyl, nitrile, nitro, or lower alkyl. <IMAGE>
Patent AU-753464-B2 (AU)
Title: Method for making manufactured aggregates from coal combustion by-products
Inventor: WU MUH-CHENG M
IPC: C04B2/06
Filed: 1999-09-22
Granted: 2002-10-17
Abstract: This is a method for producing manufactured aggreates from coal combustion by-products having sulfur. Recycle fines containing calcium hydroxide, and aluminum-containing material, and water are mixed together to form a feed mix which is agglomerated into a an gglomerated product. The agglomerated product is combined with curing fines which contain calcium oxide which together form a blended mix. The blended mix is cured using the moisture in the blended mix which is used to exothermally hydrate the calcium oxide in the blended mix to form calcium hydroxide and which autogenically provides the required heat for curing and converts the calcium oxide in the blended mix to a dry calcium hydroxide-containing material to form aggregate products and dry fines. The aggregate products are separated from the dry fines, the dry fines are recycled to the mixing step and the aggregates are taken and used as a useful product for other purposes.
Patent AU-696354-B2 (AU)
Title: Agglomerates
Inventor: REES GERAINT
IPC: C10L5/40
Filed: 1996-06-18
Granted: 1998-09-10
Abstract: PCT No. PCT/GB96/01446 Sec. 371 Date Dec. 8, 1997 Sec. 102(e) Date Dec. 8, 1997 PCT Filed Jun. 18, 1996 PCT Pub. No. WO97/00307 PCT Pub. Date Jan. 3, 1997Thermally shock-resistant chemically bonded agglomerates suitable for use as a combustible fuel or in a gasification process are produced by: (a) mixing particulate organic material comprising particulate carbonaceous fuel and/or animal excrement (such as dewatered comminuted sewage sludge) with a lignosulfonate, in the presence of water, with application of heat sufficient to maintain the lignosulfonate in fluid form, so as to deposit a film of lignosulfonate over the surface of the particulate material; (b) oxidatively conditioning the lignosulfonate coated particulate material under conditions permitting escape of water present in the mixed particulate material, the conditioning either being in the presence of calcium ions or being followed by mixing the conditioned particulate material with lime; and (c) shaping the resulting free-flowing plastic mixture under pressure, to form the thermally shock-resistant agglomerates.
Patent AU-654657-B2 (AU)
Title: Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
Inventor: WAYNER ELIZABETH
IPC: C07K14/78
Filed: 1990-08-31
Granted: 1994-11-17
Abstract: The present invention relates to a method for inhibiting the adhesion of one cell to another comprising interfering with the interaction between the extracellular matrix receptor and its ligand. The invention is based upon the discovery that the  alpha 4 beta 1 extracellular matrix receptor promotes adhesion of lymphocytes to endothelial cells via attachment to a defined peptide sequence. Prior to the present invention, the ligand of the  alpha 4 beta 1 receptor had not been identified, nor had the function of the  alpha 4 beta 1 receptor in lymphocyte attachment been known. By preventing the interaction between the  alpha 4 beta 1 receptor and its ligands using antibodies or defined peptide sequences, the present invention enables, for the first time, specific intervention in the migration of lymphocytes through the vascular endothelium and into tissues. The present invention, therefore, has particular clinical utility in suppression of the immune response, in various specific embodiments of the invention, the adherence of lymphocytes to endothelium may be inhibited systemically, or may, alternatively, be localized to particular tissues or circumscribed areas. Accordingly, the present invention provides for treatment of diseases involving autoimmune responses as well as other chronic or relapsing activations of the immune system, including allergy, asthma, and chronic inflammatory skin conditions.
Patent AU-585676-B2 (AU)
Title: Framework composed of bar-shaped elements
Inventor: ZWISSLER RUEDI
IPC: E04B1/344
Filed: 1986-11-25
Granted: 1989-06-22
Abstract: PCT No. PCT/CH86/00163 Sec. 371 Date Jul. 27, 1987 Sec. 102(e) Date Jul. 27, 1987 PCT Filed Nov. 25, 1986 PCT Pub. No. WO87/03346 PCT Pub. Date Jun. 4, 1987.Connecting elements (4) can be inserted into the ends of the individual bar-shaped elements (2), the connecting elements having a projection (13) which engages into an opening (8) at the end of the tube. In that way each individual connecting element (4) can be released even in a framework construction which has already been assembled. The bar-shaped elements (2) are exchangeable and the framework can be broken down into all individual parts.
Patent AU-685457-B2 (AU)
Title: Guanidine derivatives as inhibitors of Na+/H+ exchange in cells
Inventor: KUNO ATSUSHI
IPC: A61P9/10
Filed: 1994-05-12
Granted: 1998-01-22
Abstract: PCT No. PCT/JP94/00786 Sec. 371 Date Nov. 9, 1995 Sec. 102(e) Date Nov. 9, 1995 PCT Filed May 12, 1994 PCT Pub. No. WO94/26709 PCT Pub. Date Nov. 24, 1994Guanidine derivatives of the formula:    <IMAGE>  (I)  wherein Y is C-R1 (in which R1 is hydrogen, lower alkyl, hydroxy, protected hydroxy, etc.,) R2 is pyrrolyl, tetrazolyl, pyrazolyl, etc., R3 is hydrogen, lower alkoxy, hydroxy, protected hydroxy, etc., Z is C-R4 (in which R4 is hydrogen, carboxy, protected carboxy, nitro, halogen, hydroxy(lower)alkyl, etc.,), and W is R12 (in which R12 is hydrogen, lower alkoxy, nitro, hydroxy or protected hydroxy) and pharmaceutically acceptable salts thereof which are useful as a medicament which are useful in inhibiting Na+/H+ exchange in cells and in the prevention of cardiovascular diseases, cerebrovascular diseases, renal diseases, arteriosclerosis and shock.
Patent AU-734630-B2 (AU)
Title: A method for treating plastic film and a device in a wrapping machine
Inventor: HERAVA ISMO
IPC: B29C65/02
Filed: 1998-03-30
Granted: 2001-06-21
Abstract: A method and device for treating plastic film, according to which method plastic film web used as packaging material is wrapped around the object to be packaged. According to the method, the plastic film layers are seamed together and the plastic film web is cut off by heating the seaming point and cutting-off point by means of a heat radiator. Heat-absorbent counterpieces are preferably placed at both the seaming point and the cutting-off point, the said counterpieces being heated through the plastic layers. When the counterpieces absorb heat from the heating radiator, they heat up and at the same time heat the plastic films to be seamed and cut off. In the most advantageous embodiment, the infrared heat radiator is placed inside a tubular gripping counterpiece, which gripping counterpiece comprises slots through which the heat radiation is able to pass to the counterpieces. The color and degree of darkness of the counterpieces has been selected such that they bring about the desired temperatures in the plastic films.
Patent AU-707443-B2 (AU)
Title: Stable crystalline tetrahydrofolic acid salts
Inventor: MULLER HANS RUDOLF
IPC: A61P37/00
Filed: 1996-10-31
Granted: 1999-07-08
Abstract: Crystalline calcium salt of (6R,S)-, (6R)- and (6S)-tetrahydrofolic acid. Also claimed is the magnesium salt. The crystallisation is preferably performed in a polar medium, preferably water or a mixture of water and an organic solvent most preferably acetic acid or a lower alcohol, at pH 7-10 at an elevated temperature and/or from a dilute solution
Patent AU-716963-B2 (AU)
Title: Borate photoinitiators from polyboranes
Inventor: CUNNINGHAM ALLAN FRANCIS
IPC: C07F7/10
Filed: 1996-11-15
Granted: 2000-03-09
Abstract: Photoinitiator comprises a borane and an electron donor. Photoinitiator comprises a borane of formula (I) and an electron donor. n' = 1-50; R'1 - R'4 = phenyl or another aromatic hydrocarbon group each optionally substituted by 1-6C alkyl (itself optionally substituted by halogen, OR'6, and/or NR'8R'9), OR6, S(O)pR'7, OSO2R'7, NR'8R'9, COOR'6, CONR'8R'9, COR'10, SiR'11R'12R'13, BR'14R'15, halogen and/or P(O)qR'16R'17, with at least one of R'1 - R'4 in an ortho position to the bond to B atom-substituted phenyl or forming another sterically-hindered aromatic hydrocarbon group ortho to the B atom; p = 0 - 2; R'6 and R'7 = 1-12C alkyl (optionally substituted by COOR7a, OH, 1-12C alkoxy, CN or halogen), phenyl or phenyl-1-6C alkyl, with the phenyl optionally 1-5 times substituted by 1-6C alkyl, 1-12C alkoxy or halogen; R7a = 1-12C alkyl; R'8 - R'15 = as for R'6 or 3-12C cycloalkyl or R'8 and R'9, together with the bonded N atom, form a 5- or 6-membered ring optionally also comprising O or S atoms or R'14 and R'15, together with the bonded B atom, form a 5- or 6-membered ring; R'16 and R'17 = as for R10; q' = 0,1; X = (i) 1-12C alkylene optionally substituted by OR'6, S(O)pR'7, OSO2R'7, NR'8R'9, COOR'6, CONR'8R'9, COR'10, SiR'11R'12R'13, BR'14R15, halogen or P(O)qR'16R'17 or optionally interrupted by -O-, -S(O)p- or -NR'18-; (ii) 3-12C cycloalkylene or 2-8C alkenylene each optionally substituted by OR'6, S(O)pR'7, OSO2R'7, NR'8R9, COOR'6, CONR'8R'9, COR'10, SiR'11R'12R'13, BR'14R'15 or halogen or optionally interrupted by -O-, -S(O)p- or -NR'18-; (iii) divalent aromatic hydrocarbon residue optionally substituted by 1-6C alkyl, OR6, S(O)pR7, OSO2R'7, NR'8R'9, COOR'6, CONR'8R'9, COR'10, SiR'11R'12R'13, BR'14R'15 or halogen; or (iv) a group of formula (VII) or (VIII); Y = -(CH2)r-, -CO-, -NR'18, -O-, -S(O)p-, -CR'19R'20- or a group of formula (IV) or (V); r = 1 - 3; s = 2, 3; R'18 = H or as for R'6; R'19 and R'20 = 1-6C alkyl or phenyl or together with the bonded C atom form a 5- or 6-membered ring; A' and Q' = a single bond, -(CH2)r-, -CH:CH-, -CO- or -NR18-, S(O)p- or a group of formula (IV) or (V); or R'1 - R'4 and X = bridges containing groups of formulae (IX) and (X);   G' = -(CH2)t-, -CH:CH-, -CO- or -NR'18-, -O- or S(O)p- or a group of formula (IV) or (V); t = 0-2; and the groups of formulae (II), (III), (VI) and (VII) = are optionally substituted on the aromatic ring by OR'6, S(O)pR'7, OSO2R'7, NR'8R'9, COOR'6, CONR'8R9, COR'10, SiR'11R'12R'13, BR'14R'15 or halogen and the phenyl rings of the groups of formulae (VII), (VIII), (IX) and (X) are optionally annelated.
Patent AU-768521-B2 (AU)
Title: Coaxial connector
Inventor: VALCESCHINI JEAN-DANIEL
IPC: H01R13/46
Filed: 2000-12-14
Granted: 2003-12-18
Abstract: The connector includes additional rings ensuring accuracy of alignment for both fibres and cables. The connection terminal comprises a body (1) with a cylindrical bore (14) which is intended to receive a cylindrical insert (16). The insert (16) has a base (19) and a first roll (25) which is intended to allow its positioning on an insert support (20). A second roll (18) ensures the angular positioning of the insert in the body (1) with a conjugate female element (17). The insert support (20) is a piece formed from a hollow cylindrical component (21) followed by a cylindrical wall (23) extending along more than half of the peripheral length. This wall (23) is divided into two parts by an axial guide groove (24) co-operating with the first roll (25).
Patent AU-699228-B2 (AU)
Title: Thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
Inventor: TORGERSON PETER MARTE
IPC: A61Q5/02
Filed: 1994-06-30
Granted: 1998-11-26
Abstract: The present invention relates to water or alcohol soluble or dispersible thermoplastic elastomeric copolymers and to cosmetic and pharmaceutical compositions containing these copolymers. This invention especially relates to copolymers useful for hair styling purposes, and to hair styling compositions containing these copolymers. This invention further relates to copolymers useful for providing cosmetic and pharmaceutical compositions for topical application to the skin. These topical skin care compositions are useful for delivereing and/or transdermally transporting active ingredients to or thorugh the skin.
Patent AU-595332-B2 (AU)
Title: Method and apparatus for form-fill-seal packaging of articles
Inventor: KLINKEL WOLFGANG
IPC: B65B9/20
Filed: 1987-06-12
Granted: 1990-03-29
Abstract: A flat, flexible film web (2) is drawn off from a stock roll (3), moved over a forming shoulder (12) and thus formed into a tube (20). A longitudinal seam is made on the tube (20), the product to be packed is introduced and the package is sealed by transverse seams (17, 21). The film web (2) is driven continuously by means of drive rollers (7). The longitudinal and transverse seams are produced as the tube is being continuously advanced. A photocell (19) is used to scan printed marks on the film web (2) and a correcting means in the drive of the transverse welding jaws (40, 43) prevents the possibility of inaccuracies in the pack division being added. <IMAGE>
Patent AU-696170-B2 (AU)
Title: Galanthamine derivatives, a process for their preparation and their use as medicaments
Inventor: KOSLEY RAYMOND W JR
IPC: C07D307/26
Filed: 1994-10-14
Granted: 1998-09-03
Abstract: This application relates to compounds of the formula <CHEM> wherein R<1>, R<2> and R<3> are defined within, which compounds are useful for the treatment of memory dysfunction characterized by decreased cholinergic function, pharmaceutical compositions containing the compounds and methods for making and using the compounds.
Patent AU-635844-B2 (AU)
Title: Production of proteins using homologous recombination
IPC: C12P21/00
Filed: 1990-11-06
Granted: 1993-04-01
Abstract: Methods and compositions are provided for expression of mammalian genes in culture. An amplifiable gene is introduced by homologous recombination in juxtaposition to a target gene, the resulting combination of amplifiable gene and target gene transferred to a convenient host and the target gene amplified by means of the amplifiable gene. The resulting expression host may then be grown in culture with enhanced expression of the target gene.
Patent AU-609428-B2 (AU)
Title: Use of carboxylic acid amides
Inventor: KLAUS MICHAEL
IPC: A61K31/165
Filed: 1987-11-05
Granted: 1991-05-02
Abstract: Use of compounds of the formula    <IMAGE>  I  wherein R1, R2, R3, R4 and R5, independently are hydrogen, alkyl, or C3-7-cycloalkyl or two adjacent residues R1 to R5 taken together with adjacent carbons of the phenyl ring form a 5- to 7-membered ring optionally substituted by one or more lower alkyl groups; X is -NR7-CO- or -CO-NR7-; R6 is hydroxy, lower-alkoxy or -NR8R9; and R7, R8 and R9, independently, are hydrogen or lower-alkyl, and where R6 is hydroxy, their pharmaceutically usable salts, for the treatment of inflammatory and rheumatic diseases.
Patent AU-646293-B2 (AU)
Title: Process for preparing shaped articles made of polyurethane foams and formed articles so obtained
Inventor: LUNARDON GIANFLAVIO
IPC: C08J9/14
Filed: 1991-09-25
Granted: 1994-02-17
Abstract: Described is a process for preparing articles made of polyurethane foams, which comprises reacting at least one polyisocyanate with at least one compound containing activated terminal hydrogen atoms in the presence of an expanding medium comprising at least one hydrofluoroalkane and/or perfluoroalkane, and of a product containing at least one amino group and chemically bound or present in free form in one of the two polyurethane reactants, said expanding medium being dissolved in said one of said two polyurethane reactants.
Patent AU-648822-B2 (AU)
Title: Dosage form for time-varying patterns of drug delivery
Inventor: WONG PATRICK S L
IPC: A61K31/55
Filed: 1991-08-28
Granted: 1994-05-05
Abstract: A dosage form is disclosed that comprises means inside the dosage form for providing a substantially drug-free interval before the dosage form delivers a drug from inside the dosage form. The dosage form in an embodiment comprises a drug on the exterior of the dosage form, which drug is available for immediate delivery.
Patent AU-649728-B2 (AU)
Title: Vaccines against equine herpesviruses and the preparation thereof
Inventor: THEIN PETER
IPC: C07K14/00
Filed: 1991-10-18
Granted: 1994-06-02
Abstract: The present invention relates to vaccines for horses against infections with equine herpesviruses based on isolated glycoproteins and/or their complexes with lectins from EHV-infected cells or extracellular EHV virions.
Patent AU-651630-B2 (AU)
Title: 5-fluoro-2,4,6-pyrimidinetriamine compounds
Inventor: SCHOSTAREZ HEINRICH JOSEF
IPC: A61K8/86
Filed: 1991-09-20
Granted: 1994-07-28
Abstract: A 5-fluoro-minoxidil compound and compositions are disclosed which are useful in the treatment of hair growth and cardiovascular disorders. The 5-fluoro-minoxidil compounds have been shown to have increased transdermal transport than minoxidil and therefore can be used in decreased amounts to achieve the same pharmacological efficacy of minoxidil.
Patent AU-740926-B2 (AU)
Title: Metering circuit
Inventor: AFILANI THOMAS
IPC: A61B5/308
Filed: 1998-08-20
Granted: 2001-11-15
Abstract: A current detector and metering circuit is provided for a dielectrokinesis detecting device. This device is particularly useful in the areas of locating obscured entities, such as human beings, animals, materials, or controlled substances. A current detector is attached to an antenna and detects when subtle changes in the dielectrokinesis occurs within an detection environment. The present current detector automatically zeros itself to ambient electric field values and then has a heightened sensitivity for changes in that electrical field caused by changes in the dielectrokinesis. The present invention can be used for detection of hidden entities or substance, for motion detection, for medical diagnostic detection, and other uses.
Patent AU-717803-B2 (AU)
Title: Curable coating compositions having improved effect pigment orientation and a method of using the same
Inventor: GREEN MARVIN L
IPC: C09D201/02
Filed: 1998-11-24
Granted: 2000-03-30
Abstract: There is described a curable coating composition having at least one effect pigment which, upon cure, exhibits substantially improved orientation of the effect pigment and a corresponding improvement in appearance. The composition comprises:   (A) a carbamate-functional component having a hydrophobicity equivalent to or greater than that of a carbamate-functional compound (A') which is the reaction product of:   (1) a compound comprising a plurality of hydroxyl groups, at least one of which is the result of a ring-opening reaction between an epoxy group and an organic acid group, and   (2) cyanic acid or a compound comprising a carbamate group, and   (B) a component comprising a plurality of groups that are reactive with the carbamate functional groups on component (A), and   (C) at least one effect pigment, the curable coating composition when cured having a substantially improved effect pigment orientation. Preferably, the composition further comprises particular rheology control agents.